Well spotted Bromilyn, only your underline missed the mark. "Glacial" as in we announced a Phase 1(b) clinical trial in January 2022 and in February 2023 we're up to "final preparations are in place".
"Proud to continue to strengthen our IP". Really? "Proud"? How about "obligated" given the $3m per year as the CEO of a company developing IP? Surprised she didn't throw a "#blessed" into the mix.
#ffs.
Ann: Imugene PD1-Vaxx Immunotherapy Patent Granted in the US, page-38
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
-0.006(8.82%) |
Mkt cap ! $455.6M | |||
| Open | High | Low | Value | Volume |
| 6.9¢ | 7.1¢ | 6.2¢ | $3.774M | 58.30M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 3402693 | 6.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 610000 | 3 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |